Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Avalo Therapeutics Inc
AVTXCurrent price
12.81 USD
+0.044 USD (+0.34%)
Last closed
13.31 USD
Company
www.avalotx.com
ISIN
US05338F2074
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
129 107 008 USD
Yield for 12 month
-41.35 %
1Y
3Y
5Y
10Y
15Y
AVTX
Avalo Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development of therapies for the treatment of immune dysregulation in the Unites States. The company's drug candidates include AVTX-009, an Anti-IL-1ß monoclonal antibody which is under Phase I targeting inflammatory diseases; and AVTX-008, a fully human B and T lymphocyte attenuator agonist fusion protein for the treatment of immune dysregulation disorders. It also develops Quisovalimab (AVTX-002), an Anti-LIGHT mAb which is in phase II for immune-inflammatory diseases. The company was formerly known as Cerecor Inc. and changed its name to Avalo Therapeutics, Inc. in August 2021. Avalo Therapeutics, Inc. was incorporated in 2011 and is headquartered in Rockville, Maryland. Address: 540 Gaither Road, Rockville, MD, United States, 20850
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
35 USDP/E ratio
–Dividend Yield
–Current Year
+1 924 000 USD
Last Year
+18 051 000 USD
Current Quarter
+249 000 USD
Last Quarter
–
Current Year
+640 000 USD
Last Year
+14 617 000 USD
Current Quarter
-465 000 USD
Last Quarter
-343 000 USD
Key Figures AVTX
1 year
3 years
5 years
10 years
EBITDA
-22 050 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-20.94 %
PEG Ratio
–
Return On Equity TTM
-524.01 %
Wall Street Target Price
35 USD
Revenue TTM
807 000 USD
Book Value
9.11 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-36.3 %
Dividend Yield
–
Gross Profit TTM
-7 939 000 USD
Earnings per share
-7 126.35 USD
Diluted Eps TTM
-7 126.35 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics AVTX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History AVTX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:240
Payout Ratio
–
Last Split Date
29.12.2023
Dividend Date
–
Stock Valuation AVTX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
44.8934
Price Sales TTM
159.9839
Enterprise Value EBITDA
-0.1887
Price Book MRQ
1.6638
Financials AVTX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators AVTX
For 52 weeks
3.95 USD
25.54 USD
50 Day MA
10.31 USD
Shares Short Prior Month
54 205
200 Day MA
10.16 USD
Short Ratio
3.32
Shares Short
49 242
Short Percent
0.51 %
BeatStart